Cargando…
COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety
BACKGROUND: Data on the efficacy and safety of COVID-19 vaccines in patients with malignancy are immature. In this paper, we assessed the literature involving the use of COVID-19 vaccines in cancer patients and reported the seroconversion rates as the main outcome and severity of COVID-19 infection...
Autores principales: | Javadinia, Seyed Alireza, Alizadeh, Kimia, Mojadadi, Mohammad-Shafi, Nikbakht, Fateme, Dashti, Farzaneh, Joudi, Maryam, Harati, Hadi, Welsh, James S., Farahmand, Seyed Amir, Attarian, Fahimeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108702/ https://www.ncbi.nlm.nih.gov/pubmed/35586627 http://dx.doi.org/10.3389/fendo.2022.860238 |
Ejemplares similares
-
Anti-SARS-CoV-2 spike IgG following injection of the third dose vaccine: A systematic review with meta-analysis of heterologous versus homologous vaccination
por: Mojadadi, Mohammad-Shafi, et al.
Publicado: (2023) -
A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?
por: Joudi, Maryam, et al.
Publicado: (2022) -
COVID‐19 in cancer patients may be presented by atypical symptoms and higher mortality rate, a case‐controlled study from Iran
por: Shahidsales, Soodabeh, et al.
Publicado: (2021) -
A Systematic Review and Meta-Analysis on the Number of Adjuvant Temozolomide Cycles in Newly Diagnosed Glioblastoma
por: Attarian, Fahimeh, et al.
Publicado: (2021) -
COVID-19 Vaccination and Cancer, the Need for more Data
por: Javadinia, Seyed Alireza, et al.
Publicado: (2021)